Relief Therapeutics
Relief Therapeutics is a Swiss, commercial-stage biopharmaceutical company, developing and commercializing novel, patent-protected products in selected specialty, rare and ultra-rare diseases.
Relief Therapeutics Holding SA (RLFTF) - Yahoo Finance
Relief Therapeutics Holding SA, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of rare metabolic,...
Relief Therapeutics - Wikipedia
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. [1] The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung.
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof …
2024年9月18日 · RLF-OD032, an innovative and highly concentrated liquid formulation of sapropterin dihydrochloride, is designed to lower blood phenylalanine in adult and pediatric PKU patients. It offers a more...
Relief Therapeutics Completes Strategic Transition with Sale of …
3 天之前 · GENEVA (JAN. 22, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the sale of its intellectual property and commercialization rights for GOLIKE outside ...
Relief Therapeutics to merge with Renexxion - USA Herald
2024年11月4日 · Switzerland-based Relief Therapeutics Holding SA announced plans on Monday to merge with Renexxion Inc., a U.S. biotechnology company, in a strategic reverse merger that will bring Renexxion to the SIX Swiss Exchange.
Relief Therapeutics Announces Positive Final Results of RLF …
2024年11月11日 · RLF-TD011 is a highly pure, stabilized hypochlorous acid solution developed using Relief's proprietary TEHCLO™ technology. With strong antimicrobial properties, RLF-TD011 is a sprayable,...
Relief Therapeutics Holding SA (RLF) | Relief Therapeutics …
3 天之前 · Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US 22-Jan-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Completes Strategic Transition with Sale of …
3 天之前 · GENEVA, SWITZERLAND / ACCESS Newswire / January 22, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF) (OTCQB:RLFTF) (OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to ...
Relief Therapeutics Announces Promising Preliminary Results of …
2024年10月8日 · RLF-TD011 is a highly pure, stabilized hypochlorous acid solution developed using Relief's proprietary TEHCLO™ technology. With strong antimicrobial properties, RLF-TD011 is a sprayable,...